Nath Bio-Genes (NATHBIOGEN) | Stock Overview & Key Data
Nath Bio-Genes Performance Comparison
Stock Range
Today's Range
Low: ₹163.25
High: ₹167.59
on October 1, 2025
52 Week Range
Low: ₹137.55
High: ₹238.69
on March 12, 2025
on July 10, 2025
All-Time High: ₹585.00 on May 7, 2018
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR3.2B
EPS
21.31
P/E Ratio (TTM)
7.74
Forward P/E
N/A
P/B Ratio
0.33
PEG Ratio
0.65
Div. Yield
1.17%
ROE
5.99%
Beta
0.471
Debt to Equity
19.01
Financial Highlights
Profitability
Gross Margin
50.71%
Operating Margin
13.15%
Profit Margin
10.51%
Returns and Earnings
Return on Assets (TTM)
3.76%
Return on Equity (TTM)
5.99%
EBITDA
INR583.5M
Net Income (TTM)
INR399.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR212.97
Quarterly Revenue Growth (YoY)
16.30%
Quarterly Earnings Growth (YoY)
11.80%
Dividend Information
Last 12-Month Dividend
₹2.00
Current Dividend Yield
1.17%
3-Year Average Dividend Yield
1.00%
3-Year Average Annual Dividend
₹2.00
3-Year Total Dividends
₹6.00
Ex-Dividend Date
August 14, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Nath Bio-Genes NATHBIOGEN | 3.16B Small-cap | -3.54% | -3.25% | -21.09% | 6.87% | -12.78% | -21.44% | -2.36% | -48.74% |
| Coromandel COROMANDEL | 682.36B Large-cap | 5.25% | -2.26% | 3.04% | 11.70% | 19.33% | 42.08% | 130.74% | 218.15% |
| UPL UPLPP | 620.31B Large-cap | 0.00% | 0.00% | 16.46% | 20.65% | 129.00% | 104.96% | 104.96% | 104.96% |
| National Fertilizers NFL | 46.65B Small-cap | 3.61% | -5.06% | -4.69% | 15.13% | -19.62% | -20.39% | 91.24% | 192.73% |
| NACL Industries NACLIND | 42.69B Small-cap | -7.61% | -24.74% | -11.51% | 81.23% | 202.19% | 273.72% | 168.91% | 431.13% |
| Bharat Rasayan BHARATRAS | 42.22B Small-cap | 0.78% | -1.26% | -11.98% | -7.09% | -1.03% | -11.30% | -9.36% | 13.03% |
Ownership & Short Interest
Insider Ownership
61.40%
Institutional Ownership
2.23%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
32K
Average 90-Day Volume
19K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NATHBIOGEN's 52-week high and low?
- In the last 52 weeks, Nath Bio-Genes reached a high of ₹238.69 (on July 10, 2025) and a low of ₹137.55 (on March 12, 2025).
- What is the market cap and P/E ratio for NATHBIOGEN?
- Curious about Nath Bio-Genes's size and valuation? Its market capitalization stands at 3.16B. When it comes to valuation, the P/E ratio (trailing twelve months) is 7.74, and the forward P/E (looking ahead) is N/A.
- Does NATHBIOGEN pay dividends? If so, what's the yield?
- Yes, Nath Bio-Genes is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.17%, and the company has paid an average of ₹2.00 per share annually over the past 3 years.
- Who are Nath Bio-Genes's main competitors or similar companies to consider before investing?
When looking at Nath Bio-Genes, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Coromandel
COROMANDEL682.36B Basic Materials Agricultural Inputs 42.08% 130.74% UPL
UPLPP620.31B Basic Materials Agricultural Inputs 104.96% 104.96% National Fertilizers
NFL46.65B Basic Materials Agricultural Inputs -20.39% 91.24% NACL Industries
NACLIND42.69B Basic Materials Agricultural Inputs 273.72% 168.91% Bharat Rasayan
BHARATRAS42.22B Basic Materials Agricultural Inputs -11.30% -9.36% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Nath Bio-Genes (India) Limited? (e.g., ROE, Debt/Equity)
- To get a sense of Nath Bio-Genes's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.99%, the Debt to Equity ratio from the most recent quarter is 19.01, and its Gross Profit Margin stands at 50.71%.
- What is the recent revenue and earnings growth for NATHBIOGEN?
- Looking at Nath Bio-Genes's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.30%, and quarterly earnings saw a YoY growth of 11.80%.
- How much of NATHBIOGEN stock is held by insiders and institutions?
- Wondering who owns Nath Bio-Genes stock? Company insiders (like executives and directors) hold about 61.40% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 2.23%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.